Building on five years of success, in the third phase of the SSLN, we are supporting 16 African countries to strengthen their HIV prevention programmes through shared learning and action.

Genesis partnered with the National Institute for Communicable Diseases (NICD) on a landmark household cohort study in South Africa, central to the country’s efforts to monitor vaccine-preventable illnesses and shape national immunisation policy. From 2022 to 2025, Genesis led the SARS-CoV-2 and Multi-pathogen Serosurveillance (SAMS) longitudinal study, bringing deep expertise in data collection, management, and quality assurance to a complex, multi-year research programme.

Through literature reviews and key informant interviews, Genesis Analytics explored why individuals disengage from HIV and TB treatment, uncovering critical insights on policy gaps, administrative burdens, and stigma-related barriers. You can view the final report here

Global evidence suggests that integrating HIV services is essential for sustaining the HIV response, ending AIDS by 2030, and advancing universal health coverage.

Genesis Analytics has partnered with the Gates Foundation to explore the value of introducing and/or scaling up Wastewater and Environmental Surveillance (WES) as part of broader disease surveillance strategies.

The Gates Foundation has awarded Genesis a grant to provide technical support to the National Department of Health as part of the foundation’s $2.5-million, three-year tuberculosis (TB) delivery strategy for South Africa.